European Commission
English

Kohesio: discover EU projects in your region

   
more info
Start date: 1 November 2015
End date: 31 December 2023
Number of projects: 13
Total budget: 110 005 574,35 €
EU contribution: 64 935 217,81 €
Website: n/a
Country: European Commission Flag
Explore more: n/a
funds
ERDF: 64 935 217,81 €

1 - 13 of 13
PROJECTTOTAL BUDGETEU CONTRIBUTIONFUNDNew targeted cancer therapy with MTAP gene deletion. 15 088 941,56 € 8 772 034,73 € ERDF Construction of the Research and Development Centre for Innovative Medicines Selvita S.A. 16 650 216,65 € 7 492 597,49 € ERDF Development of targeted therapies based on the mechanism of synthetic lethality in oncology 12 323 805,88 € 7 282 804,16 € ERDF A new generation of cancer immunotherapy based on the activation of the immune response of patients 9 783 166,52 € 6 662 654,36 € ERDF Development of innovative personalised therapy of solid tumours 9 730 544,73 € 6 641 647,53 € ERDF Development of a new generation of personalised therapies targeting cancer cell metabolism 8 824 491,69 € 6 209 687,83 € ERDF Development of innovative immunotherapy of solid tumours targeting the immunosuppressive tumour microenvironment. 8 877 597,07 € 5 980 840,09 € ERDF New small-molecular immunomodulatory drugs in the treatment of resistant tumours 7 969 308,56 € 4 978 719,50 € ERDF Clinical development of an innovative candidate for a drug in the treatment of solid cancers 9 491 423,95 € 4 210 309,27 € ERDF Development of innovative DNA screening libraries to discover innovative therapeutics in the treatment of civilisation diseases 3 430 461,35 € 2 379 034,38 € ERDF Preclinical and clinical studies of anticancer active substances 3 187 313,29 € 2 221 916,53 € ERDF Extension of Selvita S.A. Research and Development Centre 4 423 592,16 € 1 990 616,47 € ERDF “Protection of intellectual property for three innovative chemicals with therapeutic potential” 224 710,94 € 112 355,47 € ERDF